chr16-2135583-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001009944.3(PKD1):c.107C>A(p.Pro36His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0219 in 1,068,452 control chromosomes in the GnomAD database, including 292 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001009944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.107C>A | p.Pro36His | missense_variant | 1/46 | ENST00000262304.9 | NP_001009944.3 | |
PKD1 | NM_000296.4 | c.107C>A | p.Pro36His | missense_variant | 1/46 | NP_000287.4 | ||
PKD1 | XM_047434208.1 | c.107C>A | p.Pro36His | missense_variant | 1/48 | XP_047290164.1 | ||
PKD1 | XM_047434209.1 | c.107C>A | p.Pro36His | missense_variant | 1/47 | XP_047290165.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.107C>A | p.Pro36His | missense_variant | 1/46 | 1 | NM_001009944.3 | ENSP00000262304 | P5 | |
PKD1 | ENST00000423118.5 | c.107C>A | p.Pro36His | missense_variant | 1/46 | 1 | ENSP00000399501 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0165 AC: 2436AN: 147602Hom.: 40 Cov.: 31
GnomAD4 exome AF: 0.0228 AC: 20963AN: 920748Hom.: 252 Cov.: 28 AF XY: 0.0227 AC XY: 9785AN XY: 430858
GnomAD4 genome AF: 0.0165 AC: 2436AN: 147704Hom.: 40 Cov.: 31 AF XY: 0.0169 AC XY: 1217AN XY: 71970
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 25, 2019 | This variant is associated with the following publications: (PMID: 22008521, 18640754) - |
Polycystic kidney disease, adult type Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 28, 2020 | - - |
Polycystic kidney disease Benign:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 p.Pro36His variant was identified in 20 of 616 proband chromosomes (frequency: 0.03) from individuals or families with ADPKD (with or without family history), and was not identified in 150 control chromosomes from healthy individuals (Reed 2008, Bataille 2011, Peltola 2005, Rossetti 2012). Reed et al. could not classify the variant however the conservation score associated the variant with some evolutionary variability (Reed 2008). The variant was identified in dbSNP (ID: rs560049593) as “With other allele”, ClinVar (classified benign by ARUP, and likely benign by Prevention Genetics and GeneDx), and ADPKD Mutation Database (classified as likely neutral). The variant was not identified in PKD1-LOVD or LOVD 3.0. The variant was identified in control databases in 398 of 26042 chromosomes (3 homozygous) at a frequency of 0.02 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 44 of 8250 chromosomes (freq: 0.005), Other in 18 of 744 chromosomes (freq: 0.02), Latino in 2 of 396 chromosomes (freq: 0.005), European Non-Finnish in 266 of 13680 chromosomes (freq: 0.02), Ashkenazi Jewish in 1 of 224 chromosomes (freq: 0.004), European Finnish in 67 of 1126 chromosomes (freq: 0.06); it was not observed in the East Asian, and South Asian populations. The p.Pro36 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact of the variant His to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory criteria to be classified as benign. - |
Autosomal dominant polycystic kidney disease Benign:1
Likely benign, criteria provided, single submitter | research | Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research | Jan 01, 2019 | - - |
PKD1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 23, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at